| Ninilchik Village Tribal Council | |
|
33880 Sterling Highway Anchor Point AK 99556 | |
| (907) 206-2733 | |
| (907) 907-2355 |
| Full Name | Ninilchik Village Tribal Council |
|---|---|
| Speciality | Clinic/center - Community Health |
| Location | 33880 Sterling Highway, Anchor Point, Alaska |
| Authorized Official Name and Position | Janet Mullen (TRIBAL HEALTH DIRECTOR) |
| Authorized Official Contact | 9075673370 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Ninilchik Village Tribal Council Po Box 39368 Ninilchik AK 99639-0368 Ph: (907) 567-3370 | Ninilchik Village Tribal Council 33880 Sterling Highway Anchor Point AK 99556 Ph: (907) 206-2733 |
| NPI Number | 1053058438 |
|---|---|
| Provider Enumeration Date | 05/17/2022 |
| Last Update Date | 05/17/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053058438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QC1500X | Clinic/center - Community Health | (* (Not Available)) | Primary |
News Archive
The American Society for Therapeutic Radiology and Oncology has published a new patient information brochure Radiation Therapy for Gynecologic Cancers: Facts to Help People Understand Their Treatment Options to help educate patients and their families about the treatments available for gynecologic cancers.
Halozyme Therapeutics, Inc. today announced that Halozyme and Baxter have confirmed the presence of small flake-like glass particles in a limited number of vials of HYLENEX® (hyaluronidase human injection) product at the Baxter manufacturing facility. Earlier today, Halozyme notified the U.S. Food and Drug Administration that it is voluntarily recalling affected lots of 150U HYLENEX product from distribution.
Investigators involved in the pivotal clinical trial of TectinTM enrolled and dosed the first of up to 150 patients that will participate in the study. It is one of the largest Canadian clinical trials to evaluate the efficacy and safety of a drug for treatment of medically refractory cancer pain, and will take place in up to 25 treatment centres across Canada.
The Centres for Disease Control and Prevention conducted a study to determine the vaccination efficacy in the adolescent population, published recently.
In the study, the researchers reviewed the results of nationally standardised tests in math and reading completed by more than 630,000 Danish schoolchildren in grades 2, 3, 4, 6 and 8. Approximately 2,000 of these children had been diagnosed with type 1 diabetes, and the comparison shows that they perform just as well as their classmates with or without adjusting for socioeconomic status.
› Verified 2 days ago